ATE548359T1 - Verbindungen und verfahren zur inhibierung der wechselwirkung von bcl-proteinen mit bindungspartnern - Google Patents
Verbindungen und verfahren zur inhibierung der wechselwirkung von bcl-proteinen mit bindungspartnernInfo
- Publication number
- ATE548359T1 ATE548359T1 AT05762701T AT05762701T ATE548359T1 AT E548359 T1 ATE548359 T1 AT E548359T1 AT 05762701 T AT05762701 T AT 05762701T AT 05762701 T AT05762701 T AT 05762701T AT E548359 T1 ATE548359 T1 AT E548359T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- inhibiting
- interaction
- methods
- binding partners
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58061604P | 2004-06-17 | 2004-06-17 | |
US65930105P | 2005-03-07 | 2005-03-07 | |
PCT/US2005/021524 WO2006009869A1 (en) | 2004-06-17 | 2005-06-17 | Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE548359T1 true ATE548359T1 (de) | 2012-03-15 |
Family
ID=35335774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05762701T ATE548359T1 (de) | 2004-06-17 | 2005-06-17 | Verbindungen und verfahren zur inhibierung der wechselwirkung von bcl-proteinen mit bindungspartnern |
Country Status (22)
Country | Link |
---|---|
US (1) | US7851637B2 (de) |
EP (1) | EP1768966B1 (de) |
JP (1) | JP5064213B2 (de) |
KR (1) | KR101195351B1 (de) |
CN (1) | CN101006065B (de) |
AT (1) | ATE548359T1 (de) |
AU (1) | AU2005265131B2 (de) |
BR (1) | BRPI0511070A (de) |
CA (1) | CA2570780C (de) |
EC (1) | ECSP067099A (de) |
ES (1) | ES2382383T3 (de) |
HK (1) | HK1105963A1 (de) |
IL (1) | IL179904A (de) |
MA (1) | MA28702B1 (de) |
MX (1) | MXPA06014754A (de) |
NO (1) | NO20070324L (de) |
NZ (1) | NZ552183A (de) |
PL (1) | PL1768966T3 (de) |
PT (1) | PT1768966E (de) |
RU (1) | RU2416606C2 (de) |
WO (1) | WO2006009869A1 (de) |
ZA (1) | ZA200610405B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2382383T3 (es) | 2004-06-17 | 2012-06-07 | Infinity Discovery, Inc. | Compuestos y procedimientos para inhibir la interacción de proteínas Bcl con componentes de unión |
US7842815B2 (en) | 2004-06-17 | 2010-11-30 | Infinity Pharmaceuticals, Inc. | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
US8624027B2 (en) * | 2005-05-12 | 2014-01-07 | Abbvie Inc. | Combination therapy for treating cancer and diagnostic assays for use therein |
TWI403320B (zh) | 2005-12-16 | 2013-08-01 | Infinity Discovery Inc | 用於抑制bcl蛋白和結合夥伴間之交互作用的化合物及方法 |
TWI389895B (zh) | 2006-08-21 | 2013-03-21 | Infinity Discovery Inc | 抑制bcl蛋白質與結合夥伴間之交互作用的化合物及方法 |
EP1897956A1 (de) | 2006-09-06 | 2008-03-12 | Lonza AG | Verfahren zur Herstellung von optisch aktiven Aminen durch Racematspaltung unter Verwendung einer bakteriellen omega-Transaminase |
CN104474529A (zh) * | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
EP2315751A1 (de) * | 2008-06-26 | 2011-05-04 | Amgen Inc. | Alkinylalkohole als kinaseinhibitoren |
DK2321640T3 (en) * | 2008-08-21 | 2017-02-27 | Immunogenics Llc | FORMULATION FOR ORAL ADMINISTRATION OF PROTEINS |
US8557983B2 (en) | 2008-12-04 | 2013-10-15 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
UA108193C2 (uk) * | 2008-12-04 | 2015-04-10 | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
US20100160322A1 (en) | 2008-12-04 | 2010-06-24 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
US8563735B2 (en) | 2008-12-05 | 2013-10-22 | Abbvie Inc. | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
US8586754B2 (en) | 2008-12-05 | 2013-11-19 | Abbvie Inc. | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
EP3101019A1 (de) * | 2008-12-05 | 2016-12-07 | AbbVie Inc. | Sulfonamides derivate als bcl-2-selektive apoptoseinduktoren zur behandlung von krebs sowie von immunerkrankungen |
CN109897038B (zh) * | 2009-05-26 | 2022-04-05 | 艾伯维爱尔兰无限公司 | 用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂 |
US8546399B2 (en) * | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
US8314250B2 (en) | 2009-11-24 | 2012-11-20 | Hoffmann-La Roche Inc. | Sultam derivatives |
US9993472B2 (en) | 2014-01-28 | 2018-06-12 | Unity Biotechnology, Inc. | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 |
WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
US10709692B2 (en) * | 2015-12-04 | 2020-07-14 | Denali Therapeutics Inc. | Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1) |
WO2017172826A1 (en) | 2016-03-28 | 2017-10-05 | Presage Biosciences, Inc. | Pharmaceutical combinations for the treatment of cancer |
WO2021233948A1 (en) | 2020-05-19 | 2021-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method to treat a pathogen lung infection |
WO2022008464A1 (en) | 2020-07-06 | 2022-01-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combination of antineoplastic antibiotics and bcl-2 inhibitors for the treatment of npm-1-driven acute myeloid leukemia (aml) |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH445129A (fr) | 1964-04-29 | 1967-10-15 | Nestle Sa | Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé |
US3459731A (en) | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
US3453257A (en) | 1967-02-13 | 1969-07-01 | Corn Products Co | Cyclodextrin with cationic properties |
US3426011A (en) | 1967-02-13 | 1969-02-04 | Corn Products Co | Cyclodextrins with anionic properties |
US3453259A (en) | 1967-03-22 | 1969-07-01 | Corn Products Co | Cyclodextrin polyol ethers and their oxidation products |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS55133364A (en) * | 1979-04-03 | 1980-10-17 | Mitsubishi Petrochem Co Ltd | Preparation of isoxazolidine derivative |
US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
DE3643012A1 (de) | 1986-12-17 | 1988-06-30 | Hoechst Ag | 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
DE3829594A1 (de) * | 1988-09-01 | 1990-03-15 | Bayer Ag | Neue renininhibitoren, verfahren zur herstellung und ihre verwendung in arzneimitteln |
DE3926822A1 (de) * | 1989-08-14 | 1991-02-21 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
KR100188801B1 (ko) | 1990-05-18 | 1999-06-01 | 엥겔하르트 라피체 | 이속사졸-4카복스아미드 및 하이드록시알킬리덴 시아노아세트아미드 및 이들 화합물을 함유하는 약제학적 조성물 |
US5294617A (en) | 1993-04-23 | 1994-03-15 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
PT730590E (pt) * | 1993-11-24 | 2001-05-31 | Du Pont Pharm Co | Derivados de isoxazolina e isoxazole como antagonistas dos reciptores do fibrinogenio |
JP2818820B2 (ja) * | 1993-11-26 | 1998-10-30 | ファイザー・インク. | 抗炎症剤としての3−アリール−2−イソオキサゾリン類 |
AU684887B2 (en) | 1994-03-09 | 1998-01-08 | Pfizer Inc. | Isoxazoline compounds as inhibitors of TNF release |
IL115849A0 (en) | 1994-11-03 | 1996-01-31 | Merz & Co Gmbh & Co | Tangential filtration preparation of liposomal drugs and liposome product thereof |
US5514505A (en) | 1995-05-15 | 1996-05-07 | Xerox Corporation | Method for obtaining improved image contrast in migration imaging members |
DE19539638A1 (de) | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
US6221865B1 (en) * | 1995-11-06 | 2001-04-24 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
IT1283836B1 (it) | 1996-08-28 | 1998-04-30 | Viv Int Spa | Procedimento per decorare profilati metallici,in materiale plastico e simili e relativa apparecchiatura |
WO1998016830A2 (en) | 1996-10-16 | 1998-04-23 | The President And Fellows Of Harvard College | Droplet assay system |
WO1998050031A1 (en) * | 1997-05-07 | 1998-11-12 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
AU7105800A (en) | 1999-09-01 | 2001-03-26 | Chemrx Advanced Technologies, Inc. | Process for synthesizing isoxazolidines |
KR100399361B1 (ko) | 1999-11-04 | 2003-09-26 | 주식회사 엘지생명과학 | 캐스파제 억제제 함유 치료제 조성물 |
CA2449245A1 (en) | 2001-05-30 | 2002-12-05 | The Regents Of The University Of Michigan | Small molecule antagonists of bcl2 family proteins |
US20030119894A1 (en) | 2001-07-20 | 2003-06-26 | Gemin X Biotechnologies Inc. | Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells |
FR2840807B1 (fr) | 2002-06-12 | 2005-03-11 | Composition cosmetique de soin et/ou de maquillage, structuree par des polymeres silicones et des organogelateurs, sous forme rigide | |
ES2382383T3 (es) | 2004-06-17 | 2012-06-07 | Infinity Discovery, Inc. | Compuestos y procedimientos para inhibir la interacción de proteínas Bcl con componentes de unión |
-
2005
- 2005-06-17 ES ES05762701T patent/ES2382383T3/es active Active
- 2005-06-17 RU RU2007101276/04A patent/RU2416606C2/ru not_active IP Right Cessation
- 2005-06-17 AT AT05762701T patent/ATE548359T1/de active
- 2005-06-17 PL PL05762701T patent/PL1768966T3/pl unknown
- 2005-06-17 MX MXPA06014754A patent/MXPA06014754A/es active IP Right Grant
- 2005-06-17 CN CN2005800281288A patent/CN101006065B/zh not_active Expired - Fee Related
- 2005-06-17 BR BRPI0511070-0A patent/BRPI0511070A/pt active Search and Examination
- 2005-06-17 US US11/156,364 patent/US7851637B2/en not_active Expired - Fee Related
- 2005-06-17 AU AU2005265131A patent/AU2005265131B2/en not_active Ceased
- 2005-06-17 EP EP05762701A patent/EP1768966B1/de active Active
- 2005-06-17 PT PT05762701T patent/PT1768966E/pt unknown
- 2005-06-17 WO PCT/US2005/021524 patent/WO2006009869A1/en active Application Filing
- 2005-06-17 JP JP2007516793A patent/JP5064213B2/ja not_active Expired - Fee Related
- 2005-06-17 CA CA2570780A patent/CA2570780C/en not_active Expired - Fee Related
- 2005-06-17 KR KR1020077001087A patent/KR101195351B1/ko not_active IP Right Cessation
- 2005-06-17 NZ NZ552183A patent/NZ552183A/en not_active IP Right Cessation
-
2006
- 2006-12-07 IL IL179904A patent/IL179904A/en not_active IP Right Cessation
- 2006-12-12 ZA ZA200610405A patent/ZA200610405B/en unknown
- 2006-12-20 EC EC2006007099A patent/ECSP067099A/es unknown
- 2006-12-29 MA MA29588A patent/MA28702B1/fr unknown
-
2007
- 2007-01-17 NO NO20070324A patent/NO20070324L/no not_active Application Discontinuation
- 2007-10-17 HK HK07111188.2A patent/HK1105963A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2382383T3 (es) | 2012-06-07 |
JP2008503489A (ja) | 2008-02-07 |
US20060025460A1 (en) | 2006-02-02 |
NO20070324L (no) | 2007-03-19 |
IL179904A (en) | 2011-11-30 |
PL1768966T3 (pl) | 2012-08-31 |
AU2005265131A1 (en) | 2006-01-26 |
KR101195351B1 (ko) | 2012-10-29 |
MXPA06014754A (es) | 2007-06-22 |
EP1768966A1 (de) | 2007-04-04 |
CN101006065B (zh) | 2012-07-11 |
WO2006009869A1 (en) | 2006-01-26 |
CN101006065A (zh) | 2007-07-25 |
EP1768966B1 (de) | 2012-03-07 |
AU2005265131B2 (en) | 2012-02-23 |
ZA200610405B (en) | 2008-03-26 |
JP5064213B2 (ja) | 2012-10-31 |
ECSP067099A (es) | 2007-04-26 |
CA2570780C (en) | 2013-12-03 |
MA28702B1 (fr) | 2007-06-01 |
CA2570780A1 (en) | 2006-01-26 |
NZ552183A (en) | 2009-10-30 |
US7851637B2 (en) | 2010-12-14 |
HK1105963A1 (en) | 2008-02-29 |
RU2416606C2 (ru) | 2011-04-20 |
BRPI0511070A (pt) | 2007-11-27 |
IL179904A0 (en) | 2007-05-15 |
PT1768966E (pt) | 2012-05-23 |
KR20070046068A (ko) | 2007-05-02 |
RU2007101276A (ru) | 2008-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE548359T1 (de) | Verbindungen und verfahren zur inhibierung der wechselwirkung von bcl-proteinen mit bindungspartnern | |
MX2009005184A (es) | Compuestos y metodos para inhibir la interaccion de las proteinas bcl con agentes aglutinantes. | |
JO2917B1 (en) | Compounds and methods to inhibit the interaction between BCL and binding partners | |
MY153232A (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
EA201000717A1 (ru) | Молекулы и способы, предназначенные для модуляции компонента системы комплемента | |
ATE554087T1 (de) | Neue kinaseinhibitoren | |
EA200870415A1 (ru) | Хиназолины для ингибирования pdk 1 | |
EA200602210A1 (ru) | Связывающие молекулы, способные нейтрализовать вирус бешенства, и их применение | |
SG171682A1 (en) | Iap bir domain binding compounds | |
MX2007011859A (es) | Compuestos mejorados farmacocineticamente. | |
EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
DE602004015811D1 (de) | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden | |
EA200800374A1 (ru) | 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции | |
MX2010004615A (es) | Anticuerpos monoclonales contra proteina c. activada e inactivada. | |
DE602004021435D1 (de) | Injizierbare zusammensetzung zur behandlung von krebs | |
ATE427933T1 (de) | Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor | |
DE602005025459D1 (de) | Ephb4-bindende antikörper zur inhibierung von angiogenese und tumorwachstum | |
TNSN06418A1 (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
MY155908A (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
EA202092981A1 (ru) | Антитела к l1cam и их применение | |
CY1115478T1 (el) | Ενωσεις τριαζολης που διαμορφωνουν δραση ηsρ90 | |
UA115859C2 (uk) | Розчинний поліпептид, який зв'язує активін а, та композиція, що його містить | |
AT501262B8 (de) | Verwendung von gallium(iii)-komplexen zur behandlung von tumoren des urothelialtraktes |